No significant HTLV seroprevalence in German people who inject drugs.
Although human T-lymphotropic virus (HTLV) is transmitted via the same routes as human immunodeficiency virus (HIV), its worldwide seroprevalence differs drastically because HTLV is transmitted mainly via infected cells rather than free virus. The sharing of needles and other equipment places people...
Main Authors: | Oliver Hohn, Stephen Norley, Claudia Kücherer, Ali Bazarbachi, Hiba El Hajj, Ulrich Marcus, Ruth Zimmermann, Norbert Bannert |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5567501?pdf=render |
Similar Items
-
High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011–14)
by: Benjamin Wenz, et al.
Published: (2016-09-01) -
Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia
by: Hiba El Hajj, et al.
Published: (2022-07-01) -
History of detention and the risk of hepatitis C among people who inject drugs in Germany
by: Martyna Gassowski, et al.
Published: (2019-04-01) -
Origin of XMRV and its Demise as a Human Pathogen Associated with Chronic Fatigue Syndrome
by: Norbert Bannert, et al.
Published: (2011-07-01) -
A large proportion of people who inject drugs are susceptible to hepatitis B: Results from a bio-behavioural study in eight German cities
by: J.M. Haussig, et al.
Published: (2018-01-01)